University of Kansas School of Medicine Infectious Disease

Topics

• Cervical Cancer and HPV Research 56
• Cystic Fibrosis Research Advances 20
• Fungal Infections and Studies 18
• Cytomegalovirus and herpesvirus research 17
• Vaccine Coverage and Hesitancy 17
• Reproductive tract infections research 15
• Influenza Virus Research Studies 13
• SARS-CoV-2 and COVID-19 Research 12
• HIV Research and Treatment 11
• Mycobacterium research and diagnosis 10
• Antifungal resistance and susceptibility 9
• Antimicrobial Resistance in Staphylococcus 9

Most cited

1. Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.

   The Lancet. Respiratory medicine · 2025 · 92 citations · Joel Mermis

2. Effectiveness of ceftazidime-avibactam versus ceftolozane-tazobactam for multidrug-resistant Pseudomonas aeruginosa infections in the USA (CACTUS): a multicentre, retrospective, observational study.

   The Lancet. Infectious diseases · 2025 · 62 citations · Ryan Kubat

3. Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.

   MMWR. Morbidity and mortality weekly report · 2022 · 153 citations · Kevin Ault

4. Determining the three-dimensional atomic structure of an amorphous solid.

   Nature · 2021 · 161 citations · Andreas Schmid

5. Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients.

   American journal of respiratory and critical care medicine · 2024 · 38 citations · Andreas Schmid

6. Geographical distribution of the Cryptococcus gattii species complex: a systematic review.

   The Lancet. Microbe · 2024 · 25 citations ·